Donor Atorvastatin Treatment in Preventing Severe Acute GVHD After Nonmyeloablative Peripheral Blood Stem Cell Transplant in Patients With Hematological Malignancies

Name: Donor Atorvastatin Treatment in Preventing Severe Acute GVHD After Nonmyeloablative Peripheral Blood Stem Cell Transplant in Patients With Hematological Malignancies
Published: 2012
License: Public Domain

Fred Hutchinson Cancer Center · 2012

ClinicalTrials.gov · Datasets · License: Public Domain · 2012

Open Source ↗

aggressive non-hodgkin lymphoma, blasts under 5 percent of bone marrow nucleated cells, chronic lymphocytic leukemia, loss of chromosome 17p, myelodysplastic/myeloproliferative neoplasm, non-hodgkin lymphoma, prolymphocytic leukemia, recurrent adult acute lymphoblastic leukemia, recurrent adult acute myeloid leukemia, recurrent aggressive adult non-hodgkin lymphoma, recurrent childhood acute lymphoblastic leukemia, recurrent childhood acute myeloid leukemia

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 992687
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.